Profile data is unavailable for this security.
About the company
Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions specifically related to limb reconstruction and deformity correction unrelated to the spine. Global Orthopedics distributes its products globally through a network of distributors and sales representatives to sell orthopedic products to hospitals and healthcare providers. It has a portfolio of biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions, and surgical navigation system. Its products are distributed in 68 countries globally via the Company's sales representatives and distributors.
- Revenue in USD (TTM)760.05m
- Net income in USD-126.48m
- Incorporated2018
- Employees1.63k
- LocationOrthofix Medical Inc3451 Plano PkwyLEWISVILLE 75056-9453United StatesUSA
- Phone+1 (214) 937-2000
- Fax+1 (302) 636-5454
- Websitehttps://ir.orthofix.com/ir-home/default.aspx
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pulmonx Corp | 72.99m | -58.73m | 347.40m | 279.00 | -- | 3.14 | -- | 4.76 | -1.54 | -1.54 | 1.91 | 2.85 | 0.399 | 1.14 | 7.81 | 261,627.20 | -32.11 | -26.27 | -35.87 | -28.97 | 74.31 | 71.95 | -80.46 | -93.76 | 6.14 | -- | 0.252 | -- | 27.98 | 27.98 | -3.26 | -- | 20.62 | -- |
Nevro Corp | 430.75m | -82.59m | 360.31m | 1.22k | -- | 1.29 | -- | 0.8365 | -2.28 | -2.28 | 11.90 | 7.59 | 0.736 | 1.14 | 6.04 | 354,523.50 | -14.11 | -13.64 | -16.06 | -16.68 | 68.94 | 68.54 | -19.17 | -20.67 | 5.57 | -- | 0.4354 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
Jin Medical International Ltd | 19.98m | 3.25m | 447.72m | 269.00 | 128.14 | 18.83 | 125.12 | 22.41 | 0.0223 | 0.0223 | 0.1353 | 0.1519 | 0.7557 | 1.85 | 5.00 | 74,260.52 | 12.28 | -- | 16.62 | -- | 33.02 | -- | 16.25 | -- | 3.02 | -- | 0.0582 | -- | -7.58 | -- | 2.84 | -- | -- | -- |
ZimVie Inc | 455.22m | -51.16m | 475.37m | 2.60k | -- | 1.22 | -- | 1.04 | -1.92 | -14.01 | 17.11 | 14.24 | 0.3299 | 1.09 | 3.73 | 175,085.40 | -3.71 | -- | -4.28 | -- | 63.05 | 65.51 | -11.24 | -8.73 | 2.23 | -0.343 | 0.5673 | -- | -1.26 | -16.08 | -19.50 | -- | -23.70 | -- |
MaxCyte Inc | 44.05m | -36.57m | 480.90m | 143.00 | -- | 2.12 | -- | 10.92 | -0.3532 | -0.3532 | 0.4253 | 2.17 | 0.1633 | 0.463 | 5.77 | 308,067.80 | -13.56 | -13.18 | -14.36 | -14.33 | 88.32 | 88.79 | -83.01 | -62.96 | 12.37 | -- | 0.00 | -- | -6.72 | 19.89 | -60.89 | -- | 39.13 | -- |
Nano-X Imaging Ltd | 9.91m | -60.78m | 501.03m | 164.00 | -- | 2.56 | -- | 50.58 | -1.08 | -1.08 | 0.1757 | 3.38 | 0.0419 | -- | 8.05 | 60,396.34 | -25.72 | -30.98 | -28.14 | -35.10 | -66.55 | -- | -613.59 | -1,527.24 | 5.56 | -- | 0.0175 | -- | 15.47 | -- | 46.33 | -- | 114.35 | -- |
Bioventus Inc | 522.74m | -21.65m | 501.57m | 995.00 | -- | 2.92 | 19.66 | 0.9595 | -0.3438 | -0.3438 | 8.30 | 2.16 | 0.6217 | 1.95 | 4.28 | 538,910.30 | -3.23 | -5.52 | -4.47 | -7.27 | 65.55 | 68.25 | -5.20 | -10.94 | 0.9745 | 1.03 | 0.6428 | -- | 0.0445 | 9.93 | 6.91 | -- | 23.51 | -- |
Surmodics Inc | 142.96m | 13.50m | 502.95m | 376.00 | 36.75 | 4.06 | 22.62 | 3.52 | 0.9597 | 0.9597 | 10.14 | 8.69 | 0.8194 | 2.05 | 6.66 | 380,220.80 | 7.74 | -1.85 | 8.69 | -2.18 | 79.11 | 82.93 | 9.44 | -2.98 | 3.59 | 9.66 | 0.1921 | -- | 32.65 | 10.27 | 94.37 | -- | -27.02 | -- |
Pacific Biosciences of California Inc | 200.43m | -296.90m | 503.86m | 796.00 | -- | 0.7761 | -- | 2.51 | -1.14 | -1.14 | 0.7695 | 2.38 | 0.1124 | 2.21 | 6.69 | 251,797.70 | -16.65 | -16.19 | -18.40 | -17.81 | 28.81 | 37.35 | -148.13 | -136.21 | 8.36 | -21.84 | 0.5791 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
Orthofix Medical Inc | 760.05m | -126.48m | 546.80m | 1.63k | -- | 0.9557 | -- | 0.7194 | -3.40 | -3.40 | 20.42 | 15.24 | 0.8338 | 1.16 | 6.36 | 465,143.80 | -13.87 | -8.88 | -16.48 | -10.96 | 66.20 | 72.37 | -16.64 | -9.28 | 1.19 | -8.38 | 0.194 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
Iradimed Corp | 67.69m | 17.92m | 551.40m | 148.00 | 30.94 | 7.24 | 29.44 | 8.15 | 1.41 | 1.41 | 5.31 | 6.01 | 0.8273 | 1.67 | 5.51 | 457,333.40 | 21.91 | 13.16 | 24.02 | 14.58 | 76.57 | 76.55 | 26.48 | 21.46 | 7.77 | -- | 0.00 | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
SI-Bone Inc | 144.05m | -43.12m | 578.10m | 344.00 | -- | 3.48 | -- | 4.01 | -1.08 | -1.08 | 3.61 | 4.03 | 0.7728 | 1.62 | 6.44 | 418,735.50 | -23.13 | -27.88 | -25.72 | -30.94 | 78.10 | 85.03 | -29.93 | -51.09 | 8.75 | -- | 0.1791 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
Varex Imaging Corp | 855.80m | 41.90m | 611.46m | 2.30k | 24.75 | 1.06 | 7.94 | 0.7145 | 0.604 | 0.604 | 16.18 | 14.10 | 0.7008 | 1.94 | 5.50 | 356,583.30 | 3.47 | 0.9913 | 4.03 | 1.18 | 32.39 | 31.70 | 4.95 | 1.36 | 2.37 | 2.57 | 0.4292 | -- | 3.96 | 2.93 | 59.08 | 18.88 | 0.2924 | -- |
Fulgent Genetics Inc | 287.53m | -165.95m | 638.88m | 1.18k | -- | 0.5648 | -- | 2.22 | -5.57 | -5.57 | 9.64 | 37.80 | 0.2206 | -- | 6.01 | 242,846.30 | -13.29 | 16.70 | -14.16 | 18.37 | 37.47 | 67.89 | -60.25 | 29.06 | -- | -- | 0.0014 | 0.00 | -53.27 | 68.41 | -217.03 | -- | 57.08 | -- |
Paragon 28 Inc | 225.44m | -54.02m | 652.83m | 430.00 | -- | 3.97 | -- | 2.90 | -0.6536 | -0.6536 | 2.73 | 1.98 | 0.6956 | 0.5405 | 5.82 | 524,267.40 | -16.67 | -- | -20.52 | -- | 79.21 | -- | -23.96 | -- | 1.78 | -6.45 | 0.4018 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
Pulse Biosciences Inc | 0.00 | -42.55m | 659.39m | 56.00 | -- | 18.17 | -- | -- | -0.8152 | -0.8152 | 0.00 | 0.6571 | 0.00 | -- | -- | 0.00 | -71.28 | -93.21 | -79.29 | -104.99 | -- | -- | -- | -12,332.25 | -- | -- | 0.00 | -- | -100.00 | -- | 27.85 | -- | -15.20 | -- |
Holder | Shares | % Held |
---|---|---|
Armistice Capital LLCas of 31 Mar 2024 | 3.70m | 9.89% |
Rubric Capital Management LPas of 31 Mar 2024 | 3.67m | 9.80% |
Engine Capital Management LPas of 19 Apr 2024 | 3.14m | 8.39% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 2.83m | 7.58% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 2.70m | 7.22% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 1.95m | 5.21% |
Paradigm Capital Management, Inc.as of 31 Mar 2024 | 1.95m | 5.21% |
Newtyn Management LLCas of 31 Mar 2024 | 1.27m | 3.40% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.07m | 2.85% |
Boone Capital Management LLCas of 31 Mar 2024 | 974.50k | 2.61% |